ObjectiveTo provide an in-depth analysis of competitive activity across key hematological indications—Acute Myeloid Leukemia (AML), Multiple Myeloma, and Acute Lymphoblastic Leukemia (ALL)—enabling the client to stay ahead in an evolving oncology landsc ...
もっと読む
2025年12月
Leveraging Competitive Intelligence: DelveInsight’s Role in Strategic Planning
Scope & ObjectiveA leading pharmaceutical company partnered with DelveInsight to gain a comprehensive understanding of the competitive environment within its target therapeutic area. The objective was to collect, analyze, and interpret strategic intellige ...
もっと読む
Competitive Benchmarking Services from DelveInsight for Pharma and Biotech Companies
Scope & ObjectiveA global pharmaceutical client engaged DelveInsight to conduct a comprehensive competitive benchmarking study. The objective was to analyze the performance, capabilities, and strategic positioning of key competitors across specific therap ...
もっと読む
New DelveInsight Study Maps the Competitive Landscape of CDMOs Across Both Regions
Scope & ObjectiveA leading pharmaceutical company collaborated with DelveInsight to gain an in-depth understanding of the Contract Development and Manufacturing Organization (CDMO) landscape across the USA and Europe. The primary objective was to identify ...
もっと読む
New DelveInsight Brief Highlights Next-Gen CAR-T Advances in B-Cell Malignancies
Scope & ObjectiveA global pharmaceutical client partnered with DelveInsight to gain comprehensive conference intelligence from the CAR-TCR Summit, with a focus on emerging CAR-T cell therapies targeting B-cell malignancies. The objective was to identify n ...
もっと読む